{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:53:08Z","timestamp":1791827588290,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2025 Innovation Project of Youjiang Medical University for Nationalities Graduate Education","award":["YXCXJH2025017"],"award-info":[{"award-number":["YXCXJH2025017"]}]},{"name":"Research Capacity Building Project for Young and Middle-aged Teachers in Guangxi Higher Education Institutions","award":["2023KY0552"],"award-info":[{"award-number":["2023KY0552"]}]},{"name":"Research Capacity Building Project for Young and Middle-aged Teachers in Guangxi Higher Education Institutions","award":["2025KY0555"],"award-info":[{"award-number":["2025KY0555"]}]},{"name":"Science and Projects of the Scientific Research and Technology Development Plan of Baise City","award":["20232030"],"award-info":[{"award-number":["20232030"]}]},{"name":"Guangxi Young Elite Scientist Sponsorship Program","award":["GXYESS2025011"],"award-info":[{"award-number":["GXYESS2025011"]}]},{"name":"General Support Policy for Young Talent (the First Batch) of Guangxi Zhuang Autonomous Region","award":["to Zongling Liu"],"award-info":[{"award-number":["to Zongling Liu"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11626-026-01188-6","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:55:33Z","timestamp":1778252133000},"page":"1168-1181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["miR-135a-5p exerts tumor-suppressive effects in 769P renal carcinoma cells through the TFAP2A\/KRT8 signaling axis"],"prefix":"10.1007","volume":"62","author":[{"given":"Delong","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3617-6417","authenticated-orcid":false,"given":"Zongling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"10","key":"1188_CR1","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.21873\/anticanres.17767","volume":"45","author":"G Aguiari","year":"2025","unstructured":"Aguiari G, Dell\u2019Atti L (2025) Clinical practice and prognostic molecular biomarkers in clear cell renal cell carcinoma: latest advancements. Anticancer Res 45(10):4131\u20134149. https:\/\/doi.org\/10.21873\/anticanres.17767","journal-title":"Anticancer Res"},{"key":"1188_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/genes16060650","author":"I Burlacu","year":"2025","unstructured":"Burlacu I, A\u0219chie M, Cozaru GC, Deacu M, Vizireanu GM, Mitroi AN et al (2025) The mir-21-5p, mir-30c-5p, and mir-182-5p as biomarkers in clear cell renal cell carcinoma: a southeastern romanian cohort study. Genes. https:\/\/doi.org\/10.3390\/genes16060650","journal-title":"Genes"},{"issue":"9","key":"1188_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa2026982","volume":"384","author":"TK Choueiri","year":"2021","unstructured":"Choueiri TK, Powles T, Burotto M, Escudier B, Bourlon MT, Zurawski B et al (2021) Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med 384(9):829\u2013841. https:\/\/doi.org\/10.1056\/NEJMoa2026982","journal-title":"N Engl J Med"},{"key":"1188_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167951","author":"T \u010cugura","year":"2025","unstructured":"\u010cugura T, Bo\u0161tjan\u010di\u010d E, Jeruc J (2025) Upregulation of mir-200c and mir-429 suggests reversal towards epithelial state in venous tumour thrombus of clear cell renal cell carcinoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26167951","journal-title":"Int J Mol Sci"},{"key":"1188_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114623","volume":"155","author":"H Gao","year":"2025","unstructured":"Gao H, Liu M, Fan M, Zhou J, Li A, Chen M (2025) Mir-135a-5p\/stat6-mediated emt regulates il-4 secretion in non-small cell lung cancer to affect m2-like tam polarization. Int Immunopharmacol 155:114623. https:\/\/doi.org\/10.1016\/j.intimp.2025.114623","journal-title":"Int Immunopharmacol"},{"key":"1188_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178618","author":"KM G\u0142uchowska","year":"2025","unstructured":"G\u0142uchowska KM, Hofman B (2025) The role of mcm7 and its hosted mir-106b-25 cluster in renal cancer progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26178618","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1188_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-021-00374-9","volume":"16","author":"M Ho","year":"2022","unstructured":"Ho M, Thompson B, Fisk JN, Nebert DW, Bruford EA, Vasiliou V et al (2022) Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disorders. Hum. Genomics 16(1):1. https:\/\/doi.org\/10.1186\/s40246-021-00374-9","journal-title":"Hum. Genomics"},{"issue":"6","key":"1188_CR8","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.3390\/cimb45060303","volume":"45","author":"X Hu","year":"2023","unstructured":"Hu X, Tan C, Zhu G (2023) Clinical characteristics of molecularly defined renal cell carcinomas. Curr Issues Mol Biol 45(6):4763\u20134777. https:\/\/doi.org\/10.3390\/cimb45060303","journal-title":"Curr Issues Mol Biol"},{"key":"1188_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102401","volume":"56","author":"H Li","year":"2025","unstructured":"Li H, Fu M, Wang L, Dai Y, Lv Z, Geng S (2025) Mir-4537 curtails ferroptosis by targeting miox in renal cell carcinoma. Transl Oncol 56:102401. https:\/\/doi.org\/10.1016\/j.tranon.2025.102401","journal-title":"Transl Oncol"},{"key":"1188_CR10","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2147\/OTT.S489559","volume":"17","author":"X Li","year":"2024","unstructured":"Li X, Qin W, Wang W, Liu W, Dong T, Liu A et al (2024) Screening and studying of blood mirnas as potential diagnostic markers for papillary thyroid carcinoma. Oncotargets Ther 17:1173\u20131185. https:\/\/doi.org\/10.2147\/OTT.S489559","journal-title":"Oncotargets Ther"},{"issue":"5","key":"1188_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2025.102390","volume":"23","author":"H Liu","year":"2025","unstructured":"Liu H, Luo G, Xie B, Chen M, Xie P, Zhao X et al (2025) The role of mir-181a-5p and its target genes in the progression of clear cell renal cell carcinoma and association with the immune microenvironment. Clin Genitourin Cancer 23(5):102390. https:\/\/doi.org\/10.1016\/j.clgc.2025.102390","journal-title":"Clin Genitourin Cancer"},{"issue":"8","key":"1188_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113060","volume":"28","author":"J Luo","year":"2025","unstructured":"Luo J, Ding Z, Chen D, Jiang Y, Cao Y, Shi M et al (2025) TFAP2A enhances tumor stemness and promotes metastasis in pancreatic ductal adenocarcinoma. Iscience 28(8):113060. https:\/\/doi.org\/10.1016\/j.isci.2025.113060","journal-title":"Iscience"},{"issue":"46","key":"1188_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000045756","volume":"104","author":"Y Ma","year":"2025","unstructured":"Ma Y, Li X, Wang X, Song B, Geng R, Hao Y et al (2025) Identification and validation of a diagnostic and prognostic model based on immune escape and cancer-associated fibroblast-related genes in lung adenocarcinoma. Medicine. (Baltimore) 104(46):e45756. https:\/\/doi.org\/10.1097\/MD.0000000000045756","journal-title":"Medicine. (Baltimore)"},{"key":"1188_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/948408","volume":"2014","author":"S M\u00fcller","year":"2014","unstructured":"M\u00fcller S, Nowak K (2014) Exploring the mirna-mrna regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. Biomed Res Int 2014:948408. https:\/\/doi.org\/10.1155\/2014\/948408","journal-title":"Biomed Res Int"},{"issue":"1","key":"1188_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05988-w","volume":"23","author":"X Niu","year":"2025","unstructured":"Niu X, Lu D, Zhan W, Sun J, Li Y, Shi Y et al (2025) Mir-9-5p\/hmmr regulates the tumorigenesis and progression of clear cell renal cell carcinoma through emt and jak1\/stat1 signaling pathway. J Transl Med 23(1):36. https:\/\/doi.org\/10.1186\/s12967-024-05988-w","journal-title":"J Transl Med"},{"key":"1188_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04359-6","author":"B Pei","year":"2025","unstructured":"Pei B, Sun H, Xu L (2025) Transcription factor TFAP2A drives the growth and metastasis and blocks ferroptosis of triple-negative breast cancer by activating PRAME transcription. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04359-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1188_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125577","author":"J Rysz","year":"2025","unstructured":"Rysz J, \u0141awi\u0144ski J, Franczyk B, Gluba-Sagr A (2025) Immune checkpoint inhibitors in clear cell renal cell carcinoma (ccRCC). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26125577","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1188_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-025-00162-0","volume":"20","author":"Q Sun","year":"2025","unstructured":"Sun Q, Qu W, Wang Y, Yang K, Weng Y (2025) TFAP2A upregulates FAM83A to suppress ferroptosis and diminish cisplatin sensitivity in non-small cell lung cancer. Cell Div 20(1):19. https:\/\/doi.org\/10.1186\/s13008-025-00162-0","journal-title":"Cell Div"},{"issue":"1","key":"1188_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-12053-z","volume":"15","author":"W Wan","year":"2025","unstructured":"Wan W, Zou J, Xie T, Zeng L, Liu H, Jiang B et al (2025) Decreased green autofluorescence in cancerous tissues is a potential biomarker for diagnosis of renal cell carcinomas. Sci. Rep 15(1):26798. https:\/\/doi.org\/10.1038\/s41598-025-12053-z","journal-title":"Sci. Rep"},{"key":"1188_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1582887","volume":"16","author":"B Wang","year":"2025","unstructured":"Wang B, Xiang Y, Liu X, Pan X, Peng L, Ma J (2025) Advances in immunotherapy and targeted therapy for advanced clear-cell renal cell carcinoma: current strategies and future directions. Front Immunol 16:1582887. https:\/\/doi.org\/10.3389\/fimmu.2025.1582887","journal-title":"Front Immunol"},{"issue":"1","key":"1188_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02251-5","volume":"10","author":"D Wang","year":"2024","unstructured":"Wang D, Gao J, Wang J, Li K, Wu Z, Liao Z et al (2024a) TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway. Cell Death Discov 10(1):491. https:\/\/doi.org\/10.1038\/s41420-024-02251-5","journal-title":"Cell Death Discov"},{"issue":"1","key":"1188_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05286-5","volume":"22","author":"M Wang","year":"2024","unstructured":"Wang M, Niu X, Wang M, Zheng P, Liu X, Cao Z et al (2024) Long non-coding RNA RP11-197K6.1 as ceRNA promotes colorectal cancer progression via miR-135a-5p\/DLX5 axis. J Transl Med 22(1):469. https:\/\/doi.org\/10.1186\/s12967-024-05286-5","journal-title":"J Transl Med"},{"issue":"3","key":"1188_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1124\/jpet.116.239707","volume":"361","author":"DD Wijayakumara","year":"2017","unstructured":"Wijayakumara DD, Mackenzie PI, McKinnon RA, Hu DG, Meech R (2017) Regulation of UDP-glucuronosyltransferases UGT2B4 and UGT2B7 by microRNAs in liver cancer cells. J Pharmacol Exp Ther 361(3):386\u2013397. https:\/\/doi.org\/10.1124\/jpet.116.239707","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"1188_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70263","volume":"39","author":"X Yang","year":"2025","unstructured":"Yang X, Zeng X, Xia N, Xie X, Long Y (2025) Circ_0003520\/miR-205-5p\/CUL4B axis drives the progression of clear cell renal carcinoma. J Biochem Mol Toxicol 39(5):e70263. https:\/\/doi.org\/10.1002\/jbt.70263","journal-title":"J Biochem Mol Toxicol"},{"issue":"8","key":"1188_CR25","doi-asserted-by":"publisher","first-page":"10239","DOI":"10.1007\/s00210-025-03848-y","volume":"398","author":"J Yuan","year":"2025","unstructured":"Yuan J, Liu J, Fai R, Liu Z (2025) TFAP2A facilitates the metastasis and radioresistance of esophageal cancer by promoting egfr transcription. Naunyn Schmiedebergs Arch Pharmacol 398(8):10239\u201310248. https:\/\/doi.org\/10.1007\/s00210-025-03848-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1188_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2022.100115","volume":"77","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wang M, Lang Z, Liu H, Liu J, Ma L (2022) Mir-135a-5p suppresses breast cancer cell proliferation, migration, and invasion by regulating BAG3. Clinics 77:100115. https:\/\/doi.org\/10.1016\/j.clinsp.2022.100115","journal-title":"Clinics"},{"issue":"3","key":"1188_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-023-01157-2","volume":"23","author":"K Zhang","year":"2023","unstructured":"Zhang K, Ding C, Liu Q, Zhu D (2023) Knockdown of LINC01087 inhibits gastric cancer malignant behavior by regulating the mir-135a-5p\/CAAP1 axis. Funct Integr Genomics 23(3):248. https:\/\/doi.org\/10.1007\/s10142-023-01157-2","journal-title":"Funct Integr Genomics"},{"issue":"15","key":"1188_CR28","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/hmg\/ddae068","volume":"33","author":"K Zhou","year":"2024","unstructured":"Zhou K, Li W, Chen L, Chen S, Liu M, Yang Z et al (2024) Highly homologous mir-135a and mir-135b converting non-small cell lung cancer from suppression to progression via enhancer switching. Hum Mol Genet 33(15):1356\u20131366. https:\/\/doi.org\/10.1093\/hmg\/ddae068","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1188_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ccs3.12016","volume":"18","author":"X Zhu","year":"2024","unstructured":"Zhu X, Dong W, Zhang M (2024) Incrna AC004943.2 regulates mir-135a-5p and PTK2\/P13K axis to promote laryngeal squamous cell carcinoma progression. J Cell Commun Signal 18(1):e12016. https:\/\/doi.org\/10.1002\/ccs3.12016","journal-title":"J Cell Commun Signal"}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-026-01188-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11626-026-01188-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-026-01188-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:38:39Z","timestamp":1791826719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11626-026-01188-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1007\/s11626-026-01188-6","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"value":"1071-2690","type":"print"},{"value":"1543-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No specific permits were needed for these experiments. The authors confirm that all methods used in the study were conducted in accordance with relevant institutional, national, and international guidelines and legislation, and that this study did not involve any protected species.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KY2025090903.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the administration committee of Youjiang Medical University for Nationalities.","order":4,"name":"Ethics","label":"Institution review board statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}